Notably, overexpression of MSI1 C-terminus increased sensitivity to chemotherapeutic drugs, thus hindering the malignant progression of GBM, which opens the possibility to treat tumor recurrence via tackling the MSI1/AGO2 complex formation. This evidence concerns the gene MSI1 and neoplasm.